The new narcolepsy drug Orzeyful, which replaces the missing brain neurotransmitter orexin and interferes with the biological mechanism of the disease, offers hope for the treatment of type 1 narcolepsy, but is not suitable for all patients and raises new questions about the causes of the disease and possible side effects. (translated)
